Literature DB >> 26058757

The association between breast cancer and thyroid cancer: a meta-analysis.

Kyle R Joseph1, Senarath Edirimanne1, Guy D Eslick2.   

Abstract

Previous studies have suggested an association between breast cancer and thyroid cancer; however, there has not been a formal meta-analysis which collates the existing evidence supporting the hypothesis that breast cancer or thyroid cancer predisposes an individual to developing the other. A systematic search was carried out using PubMed and Medline. We searched for articles containing epidemiological evidence of breast cancer following thyroid cancer and vice versa. Additionally, we searched for articles that included epidemiological data involving the incidence of all second primary malignancies (SPMs) following both breast cancer and thyroid cancer, and compared the datasets. The meta-analysis performed in a total of 18 studies showed that there is a significantly increased risk of developing thyroid cancer as a second primary malignancy of breast cancer (SIR = 1.59, 95 % confidence interval (CI) 1.28-1.99). Additionally, there was marginally increased risk of developing breast cancer as a second primary malignancy of thyroid cancer (SIR = 1.24, 95 % CI 1.16-1.33), compared to the general risk of developing a second primary malignancy following thyroid cancer. The findings suggest that the risk of developing thyroid cancer as a second primary malignancy of breast cancer and vice versa is increased compared to the background risk of developing other SPMs. The risk of developing thyroid cancer after a primary breast cancer was higher than the risk of developing breast cancer as a second primary malignancy of thyroid cancer. This suggests that the effects of treatment-related factors and specific pathological processes of each cancer may contribute to the increased risk rather than common risk factors including genetic factors. Elucidation of the common mechanisms between breast cancer and thyroid cancer will have important implications in both diagnostic and therapeutic management of these cancers. Benefit of thyroid ultrasound screening after breast cancer surgery needs to be assessed.

Entities:  

Mesh:

Year:  2015        PMID: 26058757     DOI: 10.1007/s10549-015-3456-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  20 in total

1.  Breast and thyroid cancer: A multicenter study with Accrual to Clinical Trials Network.

Authors:  Merry Peckham; Horace J Spencer; Shorabuddin Syed; William B Armstrong; Donald Gregory Farwell; Thomas J Gal; David Goldenberg; Marika D Russell; Roberto N Solis; Deanne King; Brendan C Stack
Journal:  J Surg Oncol       Date:  2022-02-23       Impact factor: 2.885

2.  Occult metastatic thyroid cancer diagnosed during breast cancer axillary sentinel node biopsy.

Authors:  Pratima Herle; Steven Boyages; Rina Hui; Najmun Nahar; Nicholas K Ngui
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-08-20

3.  The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.

Authors:  Eric L Bolf; Noelle E Gillis; Michael S Barnum; Caitlin M Beaudet; Grace Y Yu; Jennifer A Tomczak; Janet L Stein; Jane B Lian; Gary S Stein; Frances E Carr
Journal:  Horm Cancer       Date:  2019-12-21       Impact factor: 3.869

4.  Development of second primary cancer in Korean breast cancer survivors.

Authors:  Hong Kyu Jung; Suyeon Park; Nam Won Kim; Jong Eun Lee; Zisun Kim; Sun Wook Han; Sung Mo Hur; Sung Young Kim; Cheol Wan Lim; Min Hyuk Lee; Jihyoun Lee
Journal:  Ann Surg Treat Res       Date:  2017-12-01       Impact factor: 1.859

5.  Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.

Authors:  Paola Caria; Silvia Cantara; Daniela Virginia Frau; Furio Pacini; Roberta Vanni; Tinuccia Dettori
Journal:  Int J Mol Sci       Date:  2016-10-21       Impact factor: 5.923

Review 6.  Breast cancer metastases to the thyroid gland - an uncommon sentinel for diffuse metastatic disease: a case report and review of the literature.

Authors:  Agata M Plonczak; Aimee N DiMarco; Roberto Dina; Dorothy M Gujral; Fausto F Palazzo
Journal:  J Med Case Rep       Date:  2017-09-22

7.  Assessment of surveillance versus etiologic factors in the reciprocal association between papillary thyroid cancer and breast cancer.

Authors:  Pragati G Advani; Lindsay M Morton; Cari M Kitahara; Amy Berrington de Gonzalez; Cody Ramin; Megan R Haymart; Rochelle E Curtis; Sara J Schonfeld
Journal:  Cancer Epidemiol       Date:  2021-07-16       Impact factor: 2.890

8.  Spatiotemporal Co-existence of Female Thyroid and Breast Cancers in Hangzhou, China.

Authors:  Xufeng Fei; George Christakos; Zhaohan Lou; Yanjun Ren; Qingmin Liu; Jiaping Wu
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

9.  Low dose of Bisphenol A enhance the susceptibility of thyroid carcinoma stimulated by DHPN and iodine excess in F344 rats.

Authors:  Jing Zhang; Xiaochen Zhang; Yanan Li; Zhenzhen Zhou; Chuanlong Wu; Zhiyan Liu; Lanxiang Hao; Shanshan Fan; Fang Jiang; Yan Xie; Ling Jiang
Journal:  Oncotarget       Date:  2017-07-22

Review 10.  Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey.

Authors:  Christoph Reiners; Rita Schneider; Tamara Platonova; Mikhail Fridman; Uwe Malzahn; Uwe Mäder; Alexis Vrachimis; Tatiana Bogdanova; Jolanta Krajewska; Rossella Elisei; Fernanda Vaisman; Jasna Mihailovic; Gracinda Costa; Valentina Drozd
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.